The DOI matches its Crossref record; 222 of the 222 references it cites were found in a registry or an index.
Examination of the expanding pathways for the regulation of p21 expression and activity
Open accessAbstract
p21Waf1/Cip1/Sdi1 was originally identified as an inhibitor of cyclin-dependent kinases, a mediator of p53 in growth suppression and a marker of cellular senescence. p21 is required for proper cell cycle progression and plays a role in cell death, DNA repair, senescence and aging, and induced pluripotent stem cell reprogramming. Although transcriptional regulation is considered to be the initial control point for p21 expression, there is growing evidence that post-transcriptional and post-translational regulations play a critical role in p21 expression and activity. This review will briefly discuss the activity of p21 and focus on current knowledge of the determinants that control p21 transcription, mRNA stability and translation, and protein stability and activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
(2008) · doi:10.1038/nrg2290 · Cited by 5,199
The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans
Reinhart, B. J., Slack, F. J., Basson, M., Pasquinelli, A. E., Bettinger, J. C., Rougvie, A. E., Horvitz, H. R., & Ruvkun, G. (2000) · Nature · doi:10.1038/35002607 · Cited by 4,981
Stöckl, S., Göttl, C., Grifka, J., & Grässel, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350089 · Cited by 4,656
miRBase: tools for microRNA genomics
Griffiths-Jones, S., Saini, H. K., van Dongen, S., & Enright, A. J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm952 · Cited by 4,382
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
Shaw, G., & Kamen, R. (1986) · Cell · doi:10.1016/0092-8674(86)90341-7 · Cited by 4,012
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Haberland, M., Montgomery, R. L., & Olson, E. N. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2485 · Cited by 2,526
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1779 · Cited by 2,200
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
The Diverse Functions of MicroRNAs in Animal Development and Disease
Kloosterman, W. P., & Plasterk, R. H. A. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.09.009 · Cited by 2,082
PCNA, the Maestro of the Replication Fork
Moldovan, G.-L., Pfander, B., & Jentsch, S. (2007) · Cell · doi:10.1016/j.cell.2007.05.003 · Cited by 1,796
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/369574a0 · Cited by 1,655
New functional activities for the p21 family of CDK inhibitors.
LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., & Harlow, E. (1997) · Genes & Development · doi:10.1101/gad.11.7.847 · Cited by 1,402
Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., & Smith, J. R. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1063 · Cited by 1,351
Peng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341
Suppression of induced pluripotent stem cell generation by the p53–p21 pathway
Hong, H., Takahashi, K., Ichisaka, T., Aoi, T., Kanagawa, O., Nakagawa, M., Okita, K., & Yamanaka, S. (2009) · Nature · doi:10.1038/nature08235 · Cited by 1,301
Cheng, M., Olivier, P., Diehl, J. A., Fero, M., Roussel, M. F., Roberts, J. M., & Sherr, C. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1571 · Cited by 1,142
Zhou, B. P., Liao, Y., Xia, W., Spohn, B., Lee, M.-H., & Hung, M.-C. (2001) · Nature Cell Biology · doi:10.1038/35060032 · Cited by 1,135
Linking the p53 tumour suppressor pathway to somatic cell reprogramming
Kawamura, T., Suzuki, J., Wang, Y. V., Menendez, S., Morera, L. B., Raya, A., Wahl, G. M., & Belmonte, J. C. I. (2009) · Nature · doi:10.1038/nature08311 · Cited by 1,115
Richon, V. M., Sandhoff, T. W., Rifkind, R. A., & Marks, P. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180316197 · Cited by 1,090
The general transcription factors of RNA polymerase II.
Orphanides, G., Lagrange, T., & Reinberg, D. (1996) · Genes & Development · doi:10.1101/gad.10.21.2657 · Cited by 1,033
A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity
Marión, R. M., Strati, K., Li, H., Murga, M., Blanco, R., Ortega, S., Fernandez-Capetillo, O., Serrano, M., & Blasco, M. A. (2009) · Nature · doi:10.1038/nature08287 · Cited by 1,028
Inhibition of cyclin-dependent kinases by p21.
Harper, J. W., Elledge, S. J., Keyomarsi, K., Dynlacht, B., Tsai, L. H., Zhang, P., Dobrowolski, S., Bai, C., Connell-Crowley, L., & Swindell, E. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.4.387 · Cited by 1,023
Xiong, Y., Zhang, H., & Beach, D. (1992) · Cell · doi:10.1016/0092-8674(92)90518-h · Cited by 1,021
Chin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S.-L., Gottlieb, G. J., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80762-x · Cited by 979
The Ink4/Arf locus is a barrier for iPS cell reprogramming
Li, H., Collado, M., Villasante, A., Strati, K., Ortega, S., Cañamero, M., Blasco, M. A., & Serrano, M. (2009) · Nature · doi:10.1038/nature08290 · Cited by 968
PCNA: structure, functions and interactions
Kelman, Z. (1997) · Oncogene · doi:10.1038/sj.onc.1200886 · Cited by 929
The role of the cyclin-dependent kinase inhibitor p21 in apoptosis.
Gartel, A. L., & Tyner, A. L. (2002) · PubMed · Cited by 918
E2F1-Regulated MicroRNAs Impair TGFβ-Dependent Cell-Cycle Arrest and Apoptosis in Gastric Cancer
Petrocca, F., Visone, R., Onelli, M. R., Shah, M. H., Nicoloso, M. S., de Martino, I., Iliopoulos, D., Pilozzi, E., Liu, C.-G., Negrini, M., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.02.013 · Cited by 831
Lost in Transcription: p21 Repression, Mechanisms, and Consequences
Gartel, A. L., & Radhakrishnan, S. K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3995 · Cited by 818
Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit
Gu, Y., Turck, C. W., & Morgan, D. O. (1993) · Nature · doi:10.1038/366707a0 · Cited by 764
New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?
Coqueret, O. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(02)00043-0 · Cited by 751
RNA recognition: towards identifying determinants of specificity
Kenan, D. J., Query, C. C., & Keene, J. D. (1991) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(91)90088-d · Cited by 730
Niculescu, A. B., Chen, X., Smeets, M., Hengst, L., Prives, C., & Reed, S. I. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.629 · Cited by 724
Self-citationSeoane, J., Le, H.-V., & Massagué, J. (2002) · Nature · doi:10.1038/nature01119 · Cited by 684
Cloning and Characterization of HuR, a Ubiquitously Expressed Elav-like Protein
Ma, W.-J., Cheng, S., Campbell, C., Wright, A., & Furneaux, H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.8144 · Cited by 667
Transcriptional Regulation of the p21(WAF1/CIP1)Gene
Gartel, A. L., & Tyner, A. L. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4319 · Cited by 664
Hypoxic Stabilization of Vascular Endothelial Growth Factor mRNA by the RNA-binding Protein HuR
Levy, N. S., Chung, S., Furneaux, H., & Levy, A. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6417 · Cited by 663
MicroRNA-125b is a novel negative regulator of p53
Le, M. T. N., Teh, C., Shyh-Chang, N., Xie, H., Zhou, B., Korzh, V., Lodish, H. F., & Lim, B. (2009) · Genes & Development · doi:10.1101/gad.1767609 · Cited by 655
Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair
Li, R., Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/371534a0 · Cited by 643
The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein.
Siomi, H., Siomi, M. C., Nussbaum, R. L., & Dreyfuss, G. (1993) · Cell · doi:10.1016/0092-8674(93)90420-u · Cited by 641
p21-containing cyclin kinases exist in both active and inactive states.
Zhang, H., Hannon, G. J., & Beach, D. (1994) · Genes & Development · doi:10.1101/gad.8.15.1750 · Cited by 632
miR-29 miRNAs activate p53 by targeting p85α and CDC42
Park, S.-Y., Lee, J. H., Ha, M., Nam, J.-W., & Kim, V. N. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1533 · Cited by 606
Apoptosis inhibitory activity of cytoplasmic p21Cip1/WAF1 in monocytic differentiation
Asada, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1223 · Cited by 586
Requirement for PCNA in DNA Mismatch Repair at a Step Preceding DNA Resynthesis
Umar, A., Buermeyer, A. B., Simon, J. A., Thomas, D. C., Clark, A. B., Liskay, R. M., & Kunkel, T. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81323-9 · Cited by 575
MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression
Ivanovska, I., Ball, A. S., Diaz, R. L., Magnus, J. F., Kibukawa, M., Schelter, J. M., Kobayashi, S. V., Lim, L., Burchard, J., Jackson, A. L., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01977-07 · Cited by 561
Szabo, A., Dalmau, J., Manley, G., Rosenfeld, M., Wong, E., Henson, J., Posner, J. B., & Furneaux, H. M. (1991) · Cell · doi:10.1016/0092-8674(91)90184-z · Cited by 553
Gui, C.-Y., Ngo, L., Xu, W. S., Richon, V. M., & Marks, P. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307708100 · Cited by 550
HuR Regulates p21 mRNA Stabilization by UV Light
Wang, W., Furneaux, H., Cheng, H., Caldwell, M. C., Hutter, D., Liu, Y., Holbrook, N., & Gorospe, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.760-769.2000 · Cited by 539
Role of the SCFSkp2 Ubiquitin Ligase in the Degradation of p21Cip1 in S Phase
Bornstein, G., Bloom, J., Sitry-Shevah, D., Nakayama, K., Pagano, M., & Hershko, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301774200 · Cited by 494
Kim, Y.-K., Yu, J., Han, T. S., Park, S.-Y., Namkoong, B., Kim, D. H., Hur, K., Yoo, M.-W., Lee, H.-J., Yang, H.-K., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp002 · Cited by 470
Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs
Lal, A., Mazan‐Mamczarz, K., Kawai, T., Yang, X., Martindale, J. L., & Gorospe, M. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600305 · Cited by 461
Li, Y., Dowbenko, D., & Lasky, L. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109062200 · Cited by 442
Smith, M. L., Ford, J. M., Hollander, M. C., Bortnick, R. A., Amundson, S. A., Seo, Y. R., Deng, C., Hanawalt, P. C., & Fornace, A. J. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.10.3705-3714.2000 · Cited by 432
microRNAs in Vertebrate Physiology and Human Disease
Chang, T.-C., & Mendell, J. T. (2007) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.8.080706.092351 · Cited by 431
Choudhury, A. R., Ju, Z., Djojosubroto, M. W., Schienke, A., Lechel, A., Schaetzlein, S., Jiang, H., Stepczynska, A., Wang, C., Buer, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1937 · Cited by 426
Myc represses the p21 (WAF1/CIP1) promoter and interacts with Sp1/Sp3
Gartel, A. L., Ye, X., Goufman, E., Shianov, P., Hay, N., Najmabadi, F., & Tyner, A. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081074898 · Cited by 417
The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults
Zacchi, P., Gostissa, M., Uchida, T., Salvagno, C., Avolio, F., Volinia, S., Ronai, Z., Blandino, G., Schneider, C., & Sal, G. D. (2002) · Nature · doi:10.1038/nature01120 · Cited by 414
Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21 CIP1/WAF1 and cyclin D proteins
Yu, Z.-K., Gervais, J. L. M., & Zhang, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11324 · Cited by 411
MicroRNAs: A new class of regulatory genes affecting metabolism
Krützfeldt, J., & Stoffel, M. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.009 · Cited by 408
Petrocca, F., Vecchione, A., & Croce, C. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1768 · Cited by 385
Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM
Fontana, L., Fiori, M. E., Albini, S., Cifaldi, L., Giovinazzi, S., Forloni, M., Boldrini, R., Donfrancesco, A., Federici, V., Giacomini, P., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002236 · Cited by 385
Molecular mechanisms of cellular transformation by HTLV-1 Tax
Grassmann, R., Aboud, M., & Jeang, K.-T. (2005) · Oncogene · doi:10.1038/sj.onc.1208978 · Cited by 385
The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response
Zheng, H., You, H., Zhou, X. Z., Murray, S. A., Uchida, T., Wulf, G., Gu, L., Tang, X., Lu, K. P., & Xiao, Z.-X. J. (2002) · Nature · doi:10.1038/nature01116 · Cited by 383
Proteasomal Turnover of p21Cip1 Does Not Require p21Cip1 Ubiquitination
Sheaff, R. J., Singer, J. D., Swanger, J., Smitherman, M., Roberts, J. M., & Clurman, B. E. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80435-9 · Cited by 382
Coordinated leading and lagging strand synthesis during SV40 DNA replication in vitro requires PCNA
Prelich, G., & Stillman, B. (1988) · Cell · doi:10.1016/0092-8674(88)90493-x · Cited by 381
Regulation of cyclin E transcription by E2Fs and retinoblastoma protein.
Geng, Y., Eaton, E. N., Picón, M., Roberts, J. M., Lundberg, A. S., Gifford, A. M., Sardet, C., & Weinberg, R. A. (1996) · PubMed · Cited by 378
Rössig, L., Jadidi, A. S., Urbich, C., Badorff, C., Zeiher, A. M., & Dimmeler, S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5644-5657.2001 · Cited by 370
Abbas, T., Sivaprasad, U., Terai, K., Amador, V., Pagano, M., & Dutta, A. (2008) · Genes & Development · doi:10.1101/gad.1676108 · Cited by 366
Function of RNA-binding protein Musashi-1 in stem cells
Okano, H., Kawahara, H., Toriya, M., Nakao, K., Shibata, S., & Imai, T. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.02.021 · Cited by 365
Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21.
Li, Y., Jenkins, C. W., Nichols, M. A., & Xiong, Y. (1994) · PubMed · Cited by 358
Regulation of the Expression of Cyclin-Dependent Kinase Inhibitor p21 by E2A and Id Proteins
Prabhu, S., Ignatova, A., Park, S. T., & Sun, X.-H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.10.5888 · Cited by 323
Proteasome-Mediated Degradation of p21 via N-Terminal Ubiquitinylation
Bloom, J., Amador, V., Bartolini, F., DeMartino, G., & Pagano, M. (2003) · Cell · doi:10.1016/s0092-8674(03)00755-4 · Cited by 322
A conserved family of elav-like genes in vertebrates.
Good, P. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4557 · Cited by 319
Wu, S., Cetinkaya, C., Munoz-Alonso, M. J., von der Lehr, N., Bahram, F., Beuger, V., Eilers, M., Leon, J., & Larsson, L.-G. (2003) · Oncogene · doi:10.1038/sj.onc.1206145 · Cited by 317
McConnell, B. B., Starborg, M., Brookes, S., & Peters, G. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70137-x · Cited by 314
Missero, C., Di Cunto, F., Kiyokawa, H., Koff, A., & Dotto, G. P. (1996) · Genes & Development · doi:10.1101/gad.10.23.3065 · Cited by 312
Identification of HuR as a protein implicated in AUUUA‐mediated mRNA decay
Myer, V. E., Fan, X. C., & Steitz, J. A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.8.2130 · Cited by 302
The common and distinct target genes of the p53 family transcription factors
Harms, K., Nozell, S., & Chen, X. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3304-4 · Cited by 295
Self-citationGomes, N. P., Bjerke, G., Llorente, B., Szostek, S. A., Emerson, B. M., & Espinosa, J. M. (2006) · Genes & Development · doi:10.1101/gad.1398206 · Cited by 266
Cooperative effects of genes controlling the G2/M checkpoint
Chan, T. A., Hwang, P. M., Hermeking, H., Kinzler, K. W., & Vogelstein, B. (2000) · Genes & Development · doi:10.1101/gad.14.13.1584 · Cited by 262
Großhans, H., Johnson, T., Reinert, K. L., Gerstein, M., & Slack, F. J. (2005) · Developmental Cell · doi:10.1016/j.devcel.2004.12.019 · Cited by 260
MDM2 Is a Negative Regulator of p21 , Independent of p53
Zhang, Z., Wang, H., Li, M., Agrawal, S., Chen, X., & Zhang, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312264200 · Cited by 252
Self-citationHistone deacetylase inhibitors: Signalling towards p21cip1/waf1
Ocker, M., & Schneider-Stock, R. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.03.001 · Cited by 250
Proliferating cell nuclear antigen: More than a clamp for DNA polymerases
Jónsson, Z. O., & Hübscher, U. (1997) · BioEssays · doi:10.1002/bies.950191106 · Cited by 248
Lafarga, V., Cuadrado, A., Lopez de Silanes, I., Bengoechea, R., Fernandez-Capetillo, O., & Nebreda, A. R. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00210-09 · Cited by 242
The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing
Kim, Y., Starostina, N. G., & Kipreos, E. T. (2008) · Genes & Development · doi:10.1101/gad.1703708 · Cited by 240
Nishitani, H., Shiomi, Y., Iida, H., Michishita, M., Takami, T., & Tsurimoto, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806045200 · Cited by 240
Zhang, Y., Fujita, N., & Tsuruo, T. (1999) · Oncogene · doi:10.1038/sj.onc.1202426 · Cited by 237
Touitou, R. (2001) · The EMBO Journal · doi:10.1093/emboj/20.10.2367 · Cited by 236
Suzuki, A., Ito, T., Kawano, H., Hayashida, M., Hayasaki, Y., Tsutomi, Y., Akahane, K., Nakano, T., Miura, M., & Shiraki, K. (2000) · Oncogene · doi:10.1038/sj.onc.1203429 · Cited by 232
The Stress-activated Protein Kinases p38α and JNK1 Stabilize p21Cip1 by Phosphorylation
Kim, G.-Y., Mercer, S. E., Ewton, D. Z., Yan, Z., Jin, K., & Friedman, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201299200 · Cited by 230
Wulf, G. M., Liou, Y.-C., Ryo, A., Lee, S. W., & Lu, K. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200538200 · Cited by 228
Alterations in microRNA expression in stress-induced cellular senescence
Li, G., Luna, C., Qiu, J., Epstein, D. L., & Gonzalez, P. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.09.002 · Cited by 219
Glycogen Synthase Kinase-3 Couples AKT-dependent Signaling to the Regulation of p21Cip1 Degradation
Rössig, L., Badorff, C., Holzmann, Y., Zeiher, A. M., & Dimmeler, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106157200 · Cited by 218
APC/CCdc20 Controls the Ubiquitin-Mediated Degradation of p21 in Prometaphase
Amador, V., Ge, S., Santamaría, P. G., Guardavaccaro, D., & Pagano, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.013 · Cited by 209
Fang, L., Igarashi, M., Leung, J., Sugrue, M. M., Lee, S. W., & Aaronson, S. A. (1999) · Oncogene · doi:10.1038/sj.onc.1202615 · Cited by 207
MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation
Jin, Y., Lee, H., Zeng, S. X., Dai, M., & Lu, H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg600 · Cited by 206
Checkpoint Pathways Come of Age
Nurse, P. (1997) · Cell · doi:10.1016/s0092-8674(00)80476-6 · Cited by 201
Gibson, T. J., Thompson, J. D., & Heringa, J. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80152-k · Cited by 197
Notch1 modulates timing of G1-S progression by inducing SKP2 transcription and p27Kip1 degradation
Sarmento, L. M., Huang, H., Limon, A., Gordon, W., Fernandes, J., Tavares, M. J., Miele, L., Cardoso, A. A., Classon, M., & Carlesso, N. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050559 · Cited by 191
Kao, P. N., Chen, L., Brock, G., Ng, J., Kenny, J., Smith, A. J., & Corthésy, B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32048-3 · Cited by 187
Child, E. S., & Mann, D. J. (2006) · Cell Cycle · doi:10.4161/cc.5.12.2863 · Cited by 184
Chai, Y., Cui, J.-Q., Shao, N., Reddy, E. S. P., & Rao, V. N. (1999) · Oncogene · doi:10.1038/sj.onc.1202323 · Cited by 179
Battelli, C., Nikopoulos, G. N., Mitchell, J. G., & Verdi, J. M. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.09.003 · Cited by 176
Wang, Y. A., Elson, A., & Leder, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14590 · Cited by 170
King, P., Levine, T., Fremeau, R., & Keene, J. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-04-01943.1994 · Cited by 167
Xia, W., Chen, J.-S., Zhou, X., Sun, P.-R., Lee, D.-F., Liao, Y., Zhou, B. P., & Hung, M.-C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0527 · Cited by 166
Mottet, D., Pirotte, S., Lamour, V., Hagedorn, M., Javerzat, S., Bikfalvi, A., Bellahcène, A., Verdin, E. M., & CASTRONOVO, V. (2008) · Oncogene · doi:10.1038/onc.2008.371 · Cited by 163
Koutsodontis, G., Tentes, I., Papakosta, P., Moustakas, A., & Kardassis, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104130200 · Cited by 159
Human T-cell leukemia virus type 1 Tax protein transforms rat fibroblasts via two distinct pathways
Matsumoto, K., Shibata, H., Fujisawa, J., Inoue, H., Hakura, A., Tsukahara, T., & Fujii, M. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4445-4451.1997 · Cited by 155
AP4 encodes a c-MYC-inducible repressor of p21
Jung, P., Menssen, A., Mayr, D. C., & Hermeking, H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801773105 · Cited by 153
Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21
Pan, Z.-Q., Reardon, J. T., Li, L., Flores-Rozas, H., Legerski, R., Sancar, A., & Hurwitz, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.22008 · Cited by 151
Competition of CUGBP1 and calreticulin for the regulation of p21 translation determines cell fate
Iakova, P. A., Wang, G., Timchenko, L., Michalak, M., Pereira‐Smith, O. M., Smith, J. R., & Timchenko, N. A. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600052 · Cited by 149
Coqueret, O., Bérubé, G., & Nepveu, A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.16.4680 · Cited by 149
Regulation of p21WAF1/CIP1 Stability by WISp39, a Hsp90 Binding TPR Protein
Jascur, T., Brickner, H., Salles-Passador, I., Barbier, V., El Khissiin, A., Smith, B., Fotedar, R., & Fotedar, A. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.11.049 · Cited by 145
Wang, Y., Blandino, G., & Givol, D. (1999) · Oncogene · doi:10.1038/sj.onc.1202632 · Cited by 144
Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts
Baus, F., Gire, V., Fisher, D., Piette, J., & Dulić, V. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg387 · Cited by 143
Coleman, M. L., Marshall, C. J., & Olson, M. F. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg189 · Cited by 143
Overexpression of MYC causes p53 -dependent G 2 arrest of normal fibroblasts
Felsher, D. W., Zetterberg, A., Zhu, J., Tlsty, T. D., & Bishop, J. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190327097 · Cited by 138
Shu, L., Yan, W., & Chen, X. (2006) · Genes & Development · doi:10.1101/gad.1463306 · Cited by 135
Self-citationYano, M., Okano, H. J., & Okano, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411119200 · Cited by 131
Coulombe, P., Rodier, G., Bonneil, É., Thibault, P., & Meloche, S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.14.6140-6150.2004 · Cited by 131
Suzuki, A., Tsutomi, Y., Yamamoto, N., Shibutani, T., & Akahane, K. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3842 · Cited by 131
Joseph, B., Orlian, M., & Furneaux, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20511 · Cited by 127
Zhang, Y., Wang, Z., & Magnuson, N. S. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0388 · Cited by 127
LKB1 Is Recruited to the p21/WAF1 Promoter by p53 to Mediate Transcriptional Activation
Zeng, P.-Y., & Berger, S. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0999 · Cited by 124
p21WAF1 gene promoter is epigenetically silenced by CTIP2 and SUV39H1
Cherrier, T., Suzanne, S., Redel, L., Calao, M., Marban, C., Samah, B., Mukerjee, R., Schwartz, C., Gras, G. S., Sawaya, B. E., et al. (2009) · Oncogene · doi:10.1038/onc.2009.193 · Cited by 123
Paraneoplastic Encephalomyelitis Antigens Bind to the AU-rich Elements of mRNA
Liu, J., Dalmau, J., Szabo, A., Rosenfeld, M., Huber, J., & Furneaux, H. (1995) · Neurology · doi:10.1212/wnl.45.3.544 · Cited by 122
The conflicting roles of the cdk inhibitor p21(CIP1/WAF1) in apoptosis
Gartel, A. L. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.04.023 · Cited by 120
Mukherjee, S., & Conrad, S. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502278200 · Cited by 120
Protective mechanisms of p53-p21-pRb proteins against DNA damage-induced cell death
Garner, E., & Raj, K. (2008) · Cell Cycle · doi:10.4161/cc.7.3.5328 · Cited by 119
N-Acetylation and Ubiquitin-Independent Proteasomal Degradation of p21Cip1
Chen, X., Chi, Y., Bloecher, A., Aebersold, R. H., Clurman, B. E., & Roberts, J. M. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.11.011 · Cited by 118
Self-citationInvolvement of p21 Waf1/Cip1 in Protein Kinase C Alpha-Induced Cell Cycle Progression
Besson, A., & Yong, V. W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.13.4580-4590.2000 · Cited by 118
Exit from G0 and entry into the cell cycle of cells expressing p21Sdi1 antisense RNA.
Nakanishi, M., Adami, G. R., Robetorye, R. S., Noda, A., Venable, S. F., Dimitrov, D., Pereira‐Smith, O. M., & Smith, J. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4352 · Cited by 118
Giles, K. M., Daly, J. M., Beveridge, D. J., Thomson, A. M., Voon, D. C., Furneaux, H. M., Jazayeri, J. A., & Leedman, P. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208439200 · Cited by 115
Transcriptional Regulation during p21/-induced Apoptosis in Human Ovarian Cancer Cells
Wu, Q. J., Kirschmeier, P. T., Hockenberry, T., Yang, T., Brassard, D., Wang, L., McClanahan, T., Black, S., Rizzi, G., Musco, M. L., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204962200 · Cited by 115
Schwaller, J., Koeffler, H. P., Niklaus, G., Loetscher, P., Nagel, S., Fey, M., & Tobler, A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117806 · Cited by 114
MicroRNA 125a and its regulation of the p53 tumor suppressor gene
Zhang, Y.-J., Gao, J.-S., Tang, X., Tucker, L., Quesenberry, P., Rigoutsos, I., & Ramratnam, B. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.10.002 · Cited by 112
RNPC1 modulates the RNA-binding activity of, and cooperates with, HuR to regulate p21 mRNA stability
Cho, J. Y., Zhang, J., & Chen, X. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp1229 · Cited by 107
Self-citationWinters, Z., Leek, R., Bradburn, M. J., Norbury, C. J., & Harris, A. L. (2003) · Breast Cancer Research · doi:10.1186/bcr654 · Cited by 106
Weiss, R. H., Joo, A., & Randour, C. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10285 · Cited by 106
Scott, M. T., MORRICE, N. A., & Ball, K. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11529 · Cited by 105
Zbtb4 represses transcription of P21CIP1 and controls the cellular response to p53 activation
Weber, A., Marquardt, J., Elzi, D. J., Forster, N., Starke, S., Glaum, A., Yamada, D., Defossez, P., Delrow, J. J., Eisenman, R. N., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.85 · Cited by 104
Liu, R., Wang, L., Chen, G., Katoh, H., Chen, C., Liu, Y., & Zheng, P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3717 · Cited by 103
Involvement of p53 and p21 in Cellular Defects and Tumorigenesis in Atm−/− Mice
Xu, Y., Yang, E. M., Brugarolas, J., Jacks, T., & Baltimore, D. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4385 · Cited by 102
P21Cip1/WAF1 downregulation is required for efficient PCNA ubiquitination after UV irradiation
Soria, G., Podhajcer, O. L., Prives, C. L., & Gottifredi, V. (2005) · Oncogene · doi:10.1038/sj.onc.1209315 · Cited by 101
Mirk/Dyrk1B Mediates Survival during the Differentiation of C2C12Myoblasts
Mercer, S. E., Ewton, D. Z., Deng, X., Lim, S., Mazur, T. R., & Friedman, E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413594200 · Cited by 100
Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis
Philipp, J., Vo, K., Gurley, K. E., Seidel, K. D., & Kemp, C. J. (1999) · Oncogene · doi:10.1038/sj.onc.1202840 · Cited by 98
Rokudai, S., Aikawa, Y., Tagata, Y., Tsuchida, N., Taya, Y., & Kitabayashi, I. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805101200 · Cited by 96
Stat1-Dependent, p53-Independent Expression of p21 waf1 Modulates Oxysterol-Induced Apoptosis
Agrawal, S., Agarwal, M. L., Chatterjee‐Kishore, M., Stark, G. R., & Chisolm, G. M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.1981-1992.2002 · Cited by 96
Soria, G., Speroni, J., Podhajcer, O. L., Prives, C., & Gottifredi, V. (2008) · Journal of Cell Science · doi:10.1242/jcs.027730 · Cited by 94
Tumor suppressor functions for the Cdk inhibitor p21 in the mouse colon
Poole, A. J., Heap, D., Carroll, R. E., & Tyner, A. L. (2004) · Oncogene · doi:10.1038/sj.onc.1207994 · Cited by 90
Kavurma, M. M., & Khachigian, L. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305650200 · Cited by 87
Activation of p21WAF1/Cip1 Transcription through Sp1 Sites by Histone Deacetylase Inhibitor Apicidin
Han, J., Ahn, S., Kim, Y. K., Bae, G., Yoon, J., Hong, S., Lee, H. Y., Lee, Y., & Lee, H.-W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106688200 · Cited by 86
Suzuki, A., Kawano, H., Hayashida, M., Hayasaki, Y., Tsutomi, Y., & Akahane, K. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400706 · Cited by 86
Sakai, K., Gofuku, M., Kitagawa, Y., Ogasawara, T., Hirose, G., Yamazaki, M., Koh, C. S., Yanagisawa, N., & Steinman, L. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1358 · Cited by 85
The p16INK4a tumor suppressor controls p21WAF1 induction in response to ultraviolet light
Almohanna, M., Al‐Khalaf, H. H., Al‐Yousef, N., & Aboussekhra, A. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl1075 · Cited by 85
ATM and p21 Cooperate to Suppress Aneuploidy and Subsequent Tumor Development
Shen, K. C., Heng, H. H., Wang, Y., Lu, S., Liu, G., Deng, C., Brooks, S. C., & Wang, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1471 · Cited by 82
Fukuda, T., Naiki, T., Saito, M., & Irie, K. (2009) · Genes to Cells · doi:10.1111/j.1365-2443.2008.01256.x · Cited by 80
The p21 and PCNA partnership: A new twist for an old plot
Prives, C. L., & Gottifredi, V. (2008) · Cell Cycle · doi:10.4161/cc.7.24.7243 · Cited by 79
Choi, W., Jeon, B.-N., Yun, C., Kim, P.-H., Kim, S., Choi, K., Kim, S. H., & Hur, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809794200 · Cited by 78
Oku, T., Ikeda, S., Sasaki, H., Fukuda, K., Morioka, H., Ohtsuka, E., Yoshikawa, H., & Tsurimoto, T. (1998) · Genes to Cells · doi:10.1046/j.1365-2443.1998.00199.x · Cited by 77
Yang, X., Wang, W., Fan, J., Lal, A., Yang, D., Cheng, H., & Gorospe, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407535200 · Cited by 77
Sp1 and Sp3 activate p21 (WAF1/CIP1) gene transcription in the Caco-2 colon adenocarcinoma cell line
Gartel, A. L., Goufman, E., Najmabadi, F., & Tyner, A. L. (2000) · Oncogene · doi:10.1038/sj.onc.1203900 · Cited by 76
Ubiquitination of p21Cip1/WAF1 by SCFSkp2: Substrate Requirement and Ubiquitination Site Selection
Wang, W., Nacusi, L. P., Sheaff, R. J., & Liu, X. (2005) · Biochemistry · doi:10.1021/bi051071j · Cited by 75
Resistance of human nucleotide excision repair synthesis in vitro to p21Cdn1
Shivji, M. K., Ferrari, E., Ball, K., Hübscher, U., & Wood, R. D. (1998) · Oncogene · doi:10.1038/sj.onc.1202352 · Cited by 72
Tu, Y., Wu, W., Wu, T., Cao, Z., Wilkins, R. J., Toh, B. H., Cooper, M. E., & Chai, Z. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609623200 · Cited by 72
Javelaud, D., Wietzerbin, J., Delattre, O., & Besançon, F. (2000) · Oncogene · doi:10.1038/sj.onc.1203246 · Cited by 72
PDK1‐dependent activation of atypical PKC leads to degradation of the p21 tumour modifier protein
Scott, M. T., Ingram, A., & Ball, K. L. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf684 · Cited by 69
A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpointPreprint
Beckerman, R., Donner, A. J., Mattia, M., Peart, M. J., Manley, J. L., Espinosa, J. M., & Prives, C. L. (2009) · Genes & Development · doi:10.1101/gad.1795709 · Cited by 69
p21WAF1/CIP1 Is a Common Transcriptional Target of Retinoid Receptors
Tanaka, T., Suh, K. S., Lo, A. M., & Luca, L. M. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701700200 · Cited by 68
p21 stability: Linking chaperones to a cell cycle checkpoint
Liu, G., & Lozano, G. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.019 · Cited by 68
p21B, a variant of p21Waf1/Cip1, is induced by the p53 family
Nozell, S. E., & Chen, X. (2002) · Oncogene · doi:10.1038/sj.onc.1205191 · Cited by 65
Self-citationRegulatory Roles of p21 and Apurinic/Apyrimidinic Endonuclease 1 in Base Excision Repair
Tom, S., Ranalli, T. A., Podust, V. N., & Bambara, R. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m109626200 · Cited by 65
Miyamoto, S., Hidaka, K., Jin, D., & Morisaki, T. (2009) · Genes to Cells · doi:10.1111/j.1365-2443.2009.01347.x · Cited by 64
NORE1A Tumor Suppressor Candidate Modulates p21CIP1 via p53
Calvisi, D. F., Donninger, H., Vos, M. D., Birrer, M. J., Gordon, L. E., Leaner, V. D., & Clark, G. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3672 · Cited by 64
Gerards, W. L. H., JONG, W. W. D., BLOEMENDAL, H., & Boelens, W. C. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1429 · Cited by 61
Waggoner, S. A., Johannes, G. J., & Liebhaber, S. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806986200 · Cited by 59
Davis, T., Singhrao, S. K., Wyllie, F. S., Haughton, M. F., Smith, P. J., Wiltshire, M., Wynford-Thomas, D., Jones, C. J., Faragher, R. G. A., & Kipling, D. (2003) · Journal of Cell Science · doi:10.1242/jcs.00331 · Cited by 58
Stoyanova, T. I., Yoon, T., Kopanja, D., MOKYR, M. B., & Raychaudhuri, P. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00880-07 · Cited by 57
A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts.
Afshari, C. A., Nichols, M. A., Xiong, Y., & Mudryj, M. M. (1996) · PubMed · Cited by 57
Research works printed but not linked: 9
- Gartel, 2002, Mol. Cancer Ther., 1, 639
- Li, 1994, Oncogene, 9, 2261
- Geng, 1996, Oncogene, 12, 1173
- Afshari, 1996, Cell Growth Differ., 7, 979
- Weiss, 2000, J. Biol. Chem., 275, 28340, 10.1016/S0021-9258(19)65123-9 · doi:10.1016/s0021-9258(19)65123-9
- Smith, 2000, Mol. Cell. Biol., 20, 3705, 10.1128/MCB.20.10.3705-3714.2000 · doi:10.1128/mcb.20.10.3705-3714.2000 · Paper page
- Michieli, 1996, Oncogene, 12, 775
- He, 2009, FEBS Lett., 583, 3501, 10.1016/j.febslet.2009.10.007 · doi:10.1016/j.febslet.2009.10.007
- Cho, 2010, Nucleic Acids Res
Cited by
Hallmarks of Cellular Senescence
Hernandez-Segura, A., Nehme, J., & Demaria, M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.02.001 · Cited by 2,605
Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage.
Karimian, A., Ahmadi, Y., & Yousefi, B. (2016) · DNA Repair · doi:10.1016/j.dnarep.2016.04.008 · Cited by 1,110
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
Dimitrova, N., Zamudio, J. R., Jong, R. M., Soukup, D., Resnick, R., Sarma, K., Ward, A. J., Raj, A., Lee, J. T., Sharp, P. A., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.04.025 · Cited by 445
Aging Biomarker Consortium, Bao, H., Cao, J., Chen, M., Chen, M., Chen, W., Chen, X., Chen, Y., Chen, Y., Chen, Y., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2305-0 · Cited by 376
Self-citation
Metadata
- Authors
- Jung, Y.-S., Qian, Y., & Chen, X.
- Venue
- Cellular Signalling
- Publisher
- Elsevier BV
- Published
- 2010-07
- Volume
- 22
- Issue
- 7
- Pages
- 1003-1012
- ISSN
- 0898-6568 (ISSN-L)
- OpenAlex
- W2168790441
- Cited by
- 423
- References
- 222
- FWCI
- 16.53
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.